Northwestern Mutual Wealth Management
SVA

Northwestern Mutual Wealth Management’s Sinovac Biotech, Ltd SVA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
1,000
– – ﹤0.01% 4552
2026
Q1 		$0 Buy
+1,000
New – ﹤0.01% 4539
2023
Q4 		– Sell
-102
Closed -$660 – 3749
2023
Q3 		$660 Sell
102
-6
-6% -$39 ﹤0.01% 3088
2023
Q2 		$699 Buy
+108
New +$699 ﹤0.01% 3135
2022
Q4 		– Sell
-102
Closed -$1K – 3554
2022
Q3 		$1K Hold
102
– – ﹤0.01% 3063
2022
Q2 		$1K Buy
+102
New +$1K ﹤0.01% 3131
2022
Q1 		– Sell
-102
Closed -$1K – 3573
2021
Q4 		$1K Buy
102
+100
+5,000% +$980 ﹤0.01% 3104
2021
Q3 		$0 Hold
2
– – ﹤0.01% 3356
2021
Q2 		$0 Hold
2
– – ﹤0.01% 3257
2021
Q1 		$0 Hold
2
– – ﹤0.01% 3070
2020
Q4 		$0 Hold
2
– – ﹤0.01% 2987
2020
Q3 		$0 Buy
+2
New – ﹤0.01% 2770

Other funds holding SVA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HI
Horizon Investments Charlotte, North Carolina $9.13B AUM 34.49% 1-Year Est. Return

Northwestern Mutual Wealth Management's SVA Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Sinovac Biotech, Ltd (SVA) position steady in Q2 2026 at 1,000 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4552.

Northwestern Mutual Wealth Management first reported a position in SVA in Q3 2020 and has held it in 12 quarters since. The position peaked at $1K in Q3 2022. 28 funds tracked by Wall St. Rank hold SVA as of Q2 2026.

  • Northwestern Mutual Wealth Management held 1,000 shares of Sinovac Biotech, Ltd worth $0 as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Sinovac Biotech, Ltd share count unchanged in Q2 2026.
  • Sinovac Biotech, Ltd made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #4552 holding.
  • Northwestern Mutual Wealth Management first reported a position in Sinovac Biotech, Ltd in Q3 2020 and has held it in 12 quarters since.
  • Northwestern Mutual Wealth Management's Sinovac Biotech, Ltd position peaked at $1K in Q3 2022.
  • 28 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.